ساخت اکانت کاربری رایگان

مقالات پذیرفته شده کنگره

  • صفحه نخست
  • مقالات پذیرفته شده اولین کنگره بین المللی ژنتیک سرطان
بازنشر

  • Deciphering Tumor Molecular Heterogeneity in the Era of Precision Medicine.

  • Masumeh Babaei,1,*
    1. independent researcher


  • Introduction: Molecular and cellular heterogeneity are fundamental characteristics of tumors and can explain differences in disease progression, invasion, response to treatment, and the development of drug resistance. Conventional approaches based on bulk analysis, due to providing an average representation of the cell population, are unable to fully reveal rare subpopulations and distinct molecular states. In recent years, the development of single-cell technologies and spatial omics, along with advances in multi-omics analysis and artificial intelligence, has enabled the investigation of cancer at the cellular and spatial levels. The aim of this study was to investigate the role of these technologies in deciphering tumor molecular heterogeneity and to evaluate their potential for advancing precision medicine and predicting treatment response.
  • Methods: This study was conducted as a narrative and analytical review. Scientific sources related to tumor heterogeneity, single-cell sequencing, spatial omics, multi-omics analyses, artificial intelligence, precision medicine, and treatment resistance were searched in reputable scientific databases and selected based on thematic relevance, source credibility, and the significance of the findings. The primary focus was placed on recent studies and review articles, particularly sources published in 2025 and 2026, and the findings were qualitatively analyzed within the framework of the relationship between tumor biology and clinical applications.
  • Results: The review of the evidence showed that single-cell technologies can identify cellular subpopulations and molecular states hidden in bulk analyses, while spatial omics, by preserving the spatial location of cells, enables the investigation of the spatial organization of the tumor microenvironment and intercellular interactions. Integrating this information with genomic, transcriptomic, proteomic, and clinical data provides a more comprehensive view of tumor biology. Furthermore, artificial intelligence can play an important role in analyzing multilayered data, identifying complex patterns, discovering biomarkers, and predicting treatment response or resistance.
  • Conclusion: The findings indicate that the transition from the average characterization of tumors to cell-centered, spatial, and multi-omics analyses has created a new perspective for understanding the actual behavior of tumors and developing precision medicine. However, sample heterogeneity, the complexity and high volume of data, the lack of integrated standards, and the need for independent validation remain important barriers to the translation of these technologies into clinical applications. Overall, combining single-cell and spatial profiling with multi-omics and artificial intelligence can accelerate the transition from “identifying tumor characteristics” toward “predicting tumor behavior and selecting treatment tailored to the characteristics of each patient,” provided that the reproducibility, interpretability, and clinical validity of these approaches are systematically evaluated.
  • Keywords: Tumor heterogeneity, Single-cell , Spatial omics , Multi-omics , Precision medicine .

به خانواده بزرگ کنسر ژنتیکس و ژنومیکس سرطان بپیوندید!

ایجاد حساب کاربری رایگان